Expresión génica en pacientes obesos con enfermedad hepática por depósito de grasa Gene expression in obese patients with non-alcoholic steatohepatitis

Expresión génica en pacientes obesos con enfermedad hepática por depósito de grasa Gene expression in obese patients with non-alcoholic steatohepatitis

La fisiopatología de la enfermedad hepática por depósito de grasa sólo se conoce de forma parcial. En este trabajo hemos analizado la expresión génica intrahepática de citoquinas, quimioquinas, receptores celulares, factores de crecimiento, transductores de señales intracelulares y proteínas de comu...

Full description

Bibliographic Details
Main Authors:	A. Cayón, J. Crespo, A. R. Guerra, F. Pons-Romero
Format:	Article
Language:	English
Published:	Aran Ediciones 2008-04-01
Series:	Revista Espanola de Enfermedades Digestivas
Subjects:	Esteatohepatitis no alcohólica Enfermedad hepática por depósito de grasa Obesidad mórbida Non-alcoholic steatohepatitis Non-alcoholic fatty liver disease Morbid obesity
Online Access:	http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082008000400004

Similar Items

Hígado graso: Enfoque diagnóstico y terapéutico Fatty liver: Diagnostic and therapeutic approach
by: Alfredo Herrera González, et al.
Published: (2007-03-01)

Individualized exercise prescription in non-alcoholic steatohepatitis: a case report
by: Miguel Ángel Sánchez-Martos, et al.
Published: (2015-03-01)

Comparison of clinical, biochemical and histological features of alcoholic steatohepatitis and non-alcoholic steatohepatitis in Asian Indian patients
by: Singh Deepak, et al.
Published: (2010-07-01)

Structure of anaemic conditions comorbid to alcoholic and non-alcoholic steatohepatitis
by: Oksana Khukhlina, et al.
Published: (2021-05-01)

IMAGING DIAGNOSIS OF NONALCOHOLIC STEATOHEPATITIS
by: Anca Smaranda Farmazon, et al.
Published: (2018-09-01)

Esteatohepatitis no alcohólica: Fisiopatogenia y modelos experimentales Nonalcoholic esteatohepatitis: Physopathogeny and experimental models
by: Zulema Adorna Carmenate
Published: (2007-03-01)

Molecular Mechanisms and New Treatment Strategies for Non-Alcoholic Steatohepatitis (NASH)
by: Akinobu Takaki, et al.
Published: (2014-04-01)

Non-alcoholic Steatohepatitis Pathogenesis, Diagnosis, and Treatment
by: Bo Zhu, et al.
Published: (2021-09-01)

A scoring system for the diagnosis of non-alcoholic steatohepatitis from liver biopsy
by: Kyoungbun Lee, et al.
Published: (2020-05-01)

Natural Progression of Non-Alcoholic Steatohepatitis to Hepatocellular Carcinoma
by: Daryl Ramai, et al.
Published: (2021-02-01)

Nicotinic alpha‐7 acetylcholine receptor deficiency exacerbates hepatic inflammation and fibrosis in a mouse model of non‐alcoholic steatohepatitis
by: Kumi Kimura, et al.
Published: (2019-05-01)

Regulation of decorin by ursolic acid protects against non-alcoholic steatohepatitis
by: Yiyuan Zheng, et al.
Published: (2021-11-01)

The Role of Fructose in Non-Alcoholic Steatohepatitis: Old Relationship and New Insights
by: Alessandro Federico, et al.
Published: (2021-04-01)

Smad Phospho-Isoforms for Hepatocellular Carcinoma Risk Assessment in Patients with Nonalcoholic Steatohepatitis
by: Kanehiko Suwa, et al.
Published: (2020-01-01)

Non-alcoholic fatty liver disease and steatohepatitis: State of the art on effective therapeutics based on the gold standard method for diagnosis
by: Maryam Mahjoubin-Tehran, et al.
Published: (2021-08-01)

Pathogenesis, diagnosis and treatment of non-alcoholic fatty liver disease
by: Verónica Martín-Domínguez, et al.
Published: (2013-08-01)

Epidemiology of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in Japan: A focused literature review
by: Yuichiro Eguchi, et al.
Published: (2020-10-01)

Effect of telmisartan and vitamin E on liver histopathology with non‐alcoholic steatohepatitis: A randomized, open‐label, noninferiority trial
by: Shahinul Alam, et al.
Published: (2020-08-01)

Chymase as a Possible Therapeutic Target for Amelioration of Non-Alcoholic Steatohepatitis
by: Shinji Takai, et al.
Published: (2020-10-01)

Qualitative and Quantitative Evaluation of Dietary Intake in Patients with Non-Alcoholic Steatohepatitis
by: Alessandro Federico, et al.
Published: (2017-09-01)

Lipodistrofia em doente com cirrose hepática alcoólica
by: Sara Estrela, et al.
Published: (2016-03-01)

Non-alcoholic steatohepatitis-related liver cirrhosis is increasing in China: A ten-year retrospective study
by: Ji Xiong, et al.
Published: (2015-08-01)

Multiple Hits, Including Oxidative Stress, as Pathogenesis and Treatment Target in Non-Alcoholic Steatohepatitis (NASH)
by: Daisuke Kawai, et al.
Published: (2013-10-01)

Non-Alcoholic Steatohepatitis as a Risk Factor for Intrahepatic Cholangiocarcinoma and Its Prognostic Role
by: Stefania De Lorenzo, et al.
Published: (2020-10-01)

Obesity-related non-alcoholic steatohepatitis and TGF-β1 serum levels in relation to morbid obesity
by: Ricardo N Sepúlveda-Flores, MD, et al.
Published: (2002-01-01)

Presence and Implications of Sarcopenia in Non-Alcoholic Steatohepatitis
by: Gregory Habig, et al.
Published: (2021-04-01)

Impaired Response to Immunotherapy in Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma?
by: Masatoshi Kudo
Published: (2021-07-01)

Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis – Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogue
by: Samuel J. Daniels, et al.
Published: (2019-03-01)

Steatohepatitis in Children with Obesity
by: Alexander A. Zvyagin, et al.
Published: (2021-05-01)

Immunological Mechanisms in the Pathophysiology of Non-Alcoholic Steatohepatitis
by: Sven Francque, et al.
Published: (2013-10-01)

Esteatosis Hepática: ¿preludio de diabetes tipo 2 en población pediátrica?
by: Carolina Loureiro, et al.
Published: (2014-02-01)

A Mineralocorticoid Receptor Deficiency in Myeloid Cells Reduces Liver Steatosis by Impairing Activation of CD8+ T Cells in a Nonalcoholic Steatohepatitis Mouse Model
by: Natalia Muñoz-Durango, et al.
Published: (2020-12-01)

REVIEW PAPER<br>Non-alcoholic steatohepatitis (NASH)
by: János Fehér, et al.
Published: (2005-04-01)

Non-Alcoholic Steatohepatitis in Myotonic Dystrophy: DMPK Gene Mutation, Insulin Resistance and Development of Steatohepatitis
by: Rishi R. Bhardwaj, et al.
Published: (2010-03-01)

Changes in direct markers of liver fibrosis in patients with steatohepatitis non-alcoholic and alcoholic origin on the background of obesity and pathology of the biliary tract
by: A. Yu. Filippova
Published: (2017-04-01)

Сomparative Study of Progepar Efficacy in Patients with Non-Alcoholic Steatohepatitis
by: V.G. Perederii, et al.
Published: (2015-11-01)

Correlación ecológica entre consumo de bebidas alcohólicas y mortalidad por cirrosis hepática en México Ecological correlation between alcohol use and cirrhosis mortality in Mexico
by: JOSÉ NARRO-ROBLES, et al.
Published: (1997-05-01)

Cost of non-alcoholic steatohepatitis in Europe and the USA: The GAIN study
by: Jamie O'Hara, et al.
Published: (2020-10-01)

Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical Treatments
by: Cheng Peng, et al.
Published: (2020-12-01)

Meta-Analysis of Randomized Controlled Trials of Pharmacologic Agents in Non-alcoholic Steatohepatitis
by: Adnan Said, et al.
Published: (2017-07-01)